Bristol-Myers Squibb Company (BMY) · page 6 of 16
The chart highlights the 'patent cliff' risk, specifically focusing on the concentration of revenue loss in 2026.
Shareholder letter · villain_critique · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
chart 1/1 paragraph 4/4 source-note 1/1 title 1/1
Components 7
bar-stacked paragraph paragraph paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.